Next Financial Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Next Financial Group’s Portfolio IMUC Stock Details IMUC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,000	Closed	-$1K	–	2212
2018 Q3	$1K	Buy	+3,000	New	+$691	﹤0.01%	1457
2017 Q4	–	Sell	-3,000	Closed	-$1K	–	1775
2017 Q3	$1K	Buy	+3,000	New	+$1.46K	﹤0.01%	1734

Other funds holding IMUC

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Next Financial Group's IMUC Position: Q4 2018 in Review

Next Financial Group sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 3,000 shares — an estimated $1K sold.

Next Financial Group first reported a position in IMUC in Q3 2017 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

Next Financial Group reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
Next Financial Group sold 3,000 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018, an estimated $1K.
Next Financial Group first reported a position in ImmunoCellular Therapeutics, Ltd. in Q3 2017 and held it in 2 quarters.
Next Financial Group's ImmunoCellular Therapeutics, Ltd. position peaked at $1K in Q3 2018.
3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on Next Financial Group's 13F filing for Q4 2018, filed 11 Feb 2019.